The effectiveness of mRNA vaccines has been confirmed during the COVID-19 pandemic. Now, mRNA platform technology is being applied to the development of "cancer vaccines," extending its potential beyond prevention to treatment.

Our CEO, Mr. Tae-jin Kang, will be contributing a series of five expert articles to the pharmaceutical and biotechnology media outlet "THEBIO," discussing how this technology is being utilized in the development of cancer vaccines, as well as the current trends and status of the technology.

Through this series, we expect readers to gain insights into the present and future of mRNA cancer vaccine technology.

Are you aware that AI technology is essential for the production of personalized cancer vaccines? The Part 3 (Did you know AI technology is used in the production of personalized cancer vaccines?) introduces the process of producing personalized cancer vaccines, which is a representative example of the fusion of AI technology and biotechnology (BT).